VivoSTART GMP-grade leukopaks complement BioIVT’s GMP-grade human AB serum, providing a complete solution for advanced therapy development
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced the launch of its Good Manufacturing Practice (GMP-) grade VivoSTART™ leukopaks. Leukopaks contain concentrated white blood cells and are used to research and manufacture cell and gene therapies.
“This GMP-grade leukopak product introduction underscores BioIVT’s commitment to being a high quality, global immune cell provider,” said…
Morgan Sindall Construction appointed as sole contractor to deliver Phase 2 of Unity Campus
• 90,000 sq ft of wet laboratory and office space available in 2023 to let as ‘shell & core’ or ‘fully fitted turnkey solution’
• Available as suites from 3,652 sq ft, up to a single-let building of 32,500 sq ft
• First available newly constructed laboratories in the Cambridge cluster
Cambridge, 8th September 2022: Leading regional property investor and developer Howard Group has appointed Morgan Sindall Construction as sole contractor for the construction of three new wet laboratory…
Domainex Ltd., based in Cambridge UK, is a leading provider of integrated drug discovery services. As a result of the work carried out by Domainex during an in-house research programme to identify inhibitors of protein kinases TBK1 and IKK-epsilon, DMXD-011 has been nominated as a preclinical drug candidate. The molecule is orally-bioavailable and highly selective. The recent human ex-vivo data outlined below indicates this drug should be effective in the treatment of interferonopathies such as lupus, Sjögren’s syndrome, and scleroderma.
The literature (e.g. Hasan et al, 2016, Louis et al,…
PRESS RELEASE
New Study Reveals First Genetic Links in ME and Chronic Fatigue Syndrome Paving the Way for New Diagnostics and Drugs
PrecisionLife Reports 14 Genes Associated with ME/CFS at the M.E. Genetics Research Summit in Edinburgh
OXFORD, UK, September 14, 2022 – PrecisionLife, a pioneering techbio company generating the deepest insights into disease biology to create novel precision medicines for chronic diseases, today unveiled the results of its study that provides the first detailed genetic insights into the pathophysiological mechanisms underpinning Myalgic Encephalomyelitis/Chronic…
Life science and healthcare specialists – AMSBIO has launched a new set of dedicated webpages and content downloads detailing their extensive range of high quality GMP-compliant products and services.
Good Manufacturing Practice (GMP) is an internationally recognized system which ensures that products are consistently manufactured to a high-quality and provides key guidelines for the manufacture of Advanced Therapy Medicinal Products (ATMPs). Operating as an ISO 9001 registered organization - AMSBIO understand the importance of offering GMP compliant products and services with guaranteed…
WESTBROOK, Connecticut (USA) - The Lee Company is pleased to announce that it has acquired TTP Ventus Limited from TTP Group. Based near Cambridge, UK, TTP Ventus is an inventor and manufacturer of silent, compact micropumps and pump modules with unrivalled features, enabling cutting-edge innovation across the medical, life science, environmental, and industrial sectors. These products complement The Lee Company’s existing broad range of miniature fluid control components widely utilized across the same industries.
“TTP Ventus brings exciting new technology to The Lee Company, enhancing our…
XenoTech specializes in providing ADME-Tox products and research services, in particular drug metabolism and pharmacokinetics (DMPK) and drug-drug interaction (DDI) studies
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced that it has acquired XenoTech, a provider of products for ADME-Tox in vitro models and contract research services, from Sekisui Chemical, based in Japan. XenoTech specializes in ADME, DMPK and DDI testing of potential drug candidates.
This transaction demonstrates BioIVT’s continuing commitment to…
Macomics Announces the Appointment of Roche Executive, Dr Valérie Méresse Naegelen, to its Clinical Advisory Panel
Edinburgh and Cambridge, UK, 12 September 2022 - Macomics Ltd, an immuno-oncology company with world-leading expertise in macrophage biology, is pleased to announce that Dr Valérie Méresse Naegelen, Global Head of Translational Sciences Oncology at the Pharma Division of Roche has joined its panel of Clinical Advisors.
Dr Méresse Naegelen has over 20 years of experience in research and clinical development of small and large molecule compounds for various indications in oncology…
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, is highlighting recent ADME-Tox research at the 13th International Meeting of the International Society for the Study of Xenobiotics (ISSX) and 24th International Symposium on Microsomes and Drug Oxidations (MDO). This conference will be held from September 11-14 at the Westin Seattle.
“We are looking forward to meeting with the research community at ISSX,” said Dr. Christopher Black, BioIVT Senior Vice President ADME-Tox. “The ISSX conference is an important event in our year,…